Hedge Fund - Portolan Capital Management
Bio-Rad Laboratories Inc. (BIO BIOB)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q1 (2024-03-31) | $31,471,403 | 2.39% | 90,992 | $ |
| 2 | 2023 - Q4 (2023-12-31) | $18,493,202 | 1.61% | 57,274 | $ |
| 3 | 2023 - Q3 (2023-09-30) | $15,229,107 | 1.42% | 42,486 | $ |
| 4 | 2023 - Q2 (2023-06-30) | $24,657,586 | 2.18% | 65,039 | $ |
| 5 | 2023 - Q1 (2023-03-31) | $26,039,527 | 2.48% | 54,360 | $ |
| 6 | 2022 - Q4 (2022-12-31) | $26,092,666 | 2.58% | 62,053 | $ |
| 7 | 2022 - Q3 (2022-09-30) | $18,741,000 | 1.98% | 44,927 | $ |
| 8 | 2022 - Q2 (2022-06-30) | $20,771,000 | 2.09% | 41,962 | $ |
| 9 | 2022 - Q1 (2022-03-31) | $19,320,000 | 1.53% | 34,303 | $ |
| 10 | 2021 - Q4 (2021-12-31) | $14,901,000 | 1% | 19,721 | $ |
| 11 | 2021 - Q3 (2021-09-30) | $18,606,000 | 1.35% | 24,943 | $ |
| 12 | 2021 - Q2 (2021-06-30) | $7,441,000 | 0.53% | 11,549 | $ |
| 13 | 2021 - Q1 (2021-03-31) | $6,904,000 | 0.54% | 12,088 | $ |
| 14 | 2020 - Q4 (2020-12-31) | $7,065,000 | 0.64% | 12,119 | $ |
| 15 | 2020 - Q3 (2020-09-30) | $9,205,000 | 1.04% | 17,857 | $ |
| 16 | 2020 - Q2 (2020-06-30) | $16,315,000 | 1.86% | 36,135 | $ |
| 17 | 2020 - Q1 (2020-03-31) | $23,016,000 | 3.45% | 65,656 | $ |
| 18 | 2019 - Q4 (2019-12-31) | $29,914,000 | 3.02% | 80,841 | $ |
| 19 | 2019 - Q3 (2019-09-30) | $26,551,000 | 2.99% | 79,795 | $ |
| 20 | 2019 - Q2 (2019-06-30) | $26,523,000 | 2.85% | 84,848 | $ |
| 21 | 2019 - Q1 (2019-03-31) | $24,543,000 | 2.52% | 80,291 | $ |
| 22 | 2018 - Q4 (2018-12-31) | $10,772,000 | 1.33% | 46,388 | $ |
| 23 | 2018 - Q3 (2018-09-30) | $16,398,000 | 1.61% | 52,390 | $ |
| 24 | 2018 - Q2 (2018-06-30) | $15,516,000 | 1.58% | 53,775 | $ |
| 25 | 2018 - Q1 (2018-03-31) | $14,057,000 | 1.53% | 56,210 | $ |
| 26 | 2017 - Q4 (2017-12-31) | $16,487,000 | 1.8% | 69,080 | $ |
| 27 | 2017 - Q3 (2017-09-30) | $17,246,000 | 2.05% | 77,607 | $ |
| 28 | 2017 - Q2 (2017-06-30) | $20,126,000 | 2.58% | 88,931 | $ |
| 29 | 2017 - Q1 (2017-03-31) | $15,797,000 | 2.05% | 79,246 | $ |
| 30 | 2016 - Q4 (2016-12-31) | $14,402,000 | 1.93% | 79,009 | $ |
| 31 | 2016 - Q3 (2016-09-30) | $17,617,000 | 2.41% | 107,543 | $ |
| 32 | 2016 - Q2 (2016-06-30) | $12,242,000 | 1.76% | 85,597 | $ |
| 33 | 2016 - Q1 (2016-03-31) | $10,679,000 | 1.42% | 78,108 | $ |
| 34 | 2015 - Q4 (2015-12-31) | $3,616,000 | 0.45% | 26,077 | $ |
| 35 | 2014 - Q4 (2014-12-31) | $0 | 0% | 0 | $ |
| 36 | 2014 - Q3 (2014-09-30) | $5,822,000 | 1.32% | 51,339 | $ |
| 37 | 2014 - Q2 (2014-06-30) | $2,455,000 | 0.53% | 20,507 | $ |
The displayed share prices are average quarterly stock market prices.